Patent · US Active

Combination therapies for treatment of spinal muscular atrophy

US10420753B2 · kind B2 · utility

0Cited by

7References

18Claims

0Family size

Assignee

INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION · US

Inventors

Elliot J. Androphy · Natick, US
Kevin Hodgetts · Killingworth, US
Alyssa Nicole Calder · Cambridge, US

Key dates

Filing date	Jan 5, 2018
Grant date	Sep 24, 2019
Priority date	—
Expiry date	Jan 5, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for treatment of spinal muscular atrophy (SMA). In certain embodiments, compounds are provided that increase full-length survival of motor neuron (SMN) protein production by an SMN2 gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.